Due to these similarities, it has been hypothesized that the DNA repair defects that sensitize BRCA1-deficient breast cancer tumors to platinum may also be present in TNBC, indicating that platinum-based chemotherapies may be an effective treatment option for this subset of breast cancer (4). Here, BRCA1 is linked to breast cancer.